Stanley-Laman Group’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-32,030
Closed -$1.04M 298
2019
Q4
$1.04M Buy
32,030
+1,582
+5% +$52K 0.25% 134
2019
Q3
$1.04M Sell
30,448
-222
-0.7% -$7.68K 0.26% 125
2019
Q2
$952K Sell
30,670
-2,148
-7% -$63.3K 0.23% 147
2019
Q1
$942K Sell
32,818
-194
-0.6% -$5.87K 0.23% 140
2018
Q4
$941K Buy
+33,012
New +$1.03M 0.26% 116

Other funds holding NEOG

Stanley-Laman Group's NEOG Position: Q1 2020 in Review

Stanley-Laman Group sold out of Neogen (NEOG) in Q1 2020, closing a stake of 32,030 shares — an estimated $1.04M sold.

Stanley-Laman Group first reported a position in NEOG in Q4 2018 and held it in 5 quarters. The position peaked at $1.04M in Q4 2019. 274 funds tracked by Wall St. Rank hold NEOG as of Q1 2020.

  • Stanley-Laman Group reported no remaining Neogen position as of Q1 2020 after selling out during the quarter.
  • Stanley-Laman Group sold 32,030 Neogen shares in Q1 2020, an estimated $1.04M.
  • Stanley-Laman Group first reported a position in Neogen in Q4 2018 and held it in 5 quarters.
  • Stanley-Laman Group's Neogen position peaked at $1.04M in Q4 2019.
  • 274 funds tracked by Wall St. Rank held Neogen as of Q1 2020.

Based on Stanley-Laman Group's 13F filing for Q1 2020, filed 12 May 2020.